Equation (Equation)
Pregabalin Capsule
Product Images NDC 80425-0177
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 80425-0177). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Fig 1 (Fig 1)
This text appears to be a chart with data on the percentage of patients who improved and the percent improvement in pain from baseline. However, the chart is not very clear and some of the characters are not readable. Therefore, a useful description cannot be generated.*
Fig 10 (Fig 10)
This appears to be a chart or graph representing the percentage of subjects without "LTR". It seems to show various percentages (ranging from 0 to 100, in increments of 10) on the y-axis, and days (ranging from 0 to 180, in increments of 20) on the x-axis. There are two lines on the graph labeled "Progabain" and "Placebo". However, without additional context or information about what "LTR" refers to, it is difficult to provide a specific description or interpretation.*
Fig 11 (Fig 11)
Fig 12 (Fig 12)
The text doesn't provide enough information to generate a useful description. It seems to show some numbers related to a study of pregabalin and a placebo, but there is no context or explanation.*
Fig 2 (Fig 2)
The text is providing data related to the percent of patients improved and the percent improvement in pain from baseline. The data seems to be related to a medication called "Pregabalin" with a dose of 160 mg. However, the rest of the text is not readable and does not provide any useful information.*
Fig 3 (Fig 3)
The text is presenting data on the percent of patients improved and the level of pain reduction from various medications including Pregatalin and Pregabain administered at different dosages. It also includes a chart showing the percent improvement in pain over time.*
Fig 4 (Fig 4)
Fig 5 (Fig 5)
The text contains information related to a medical study where three different treatments were administered to patients. Two of the treatments involved the drugs "Fregabalin" and "Pregataiin" in different dosages, while the third treatment was a placebo. A chart is also included, showing the percentage improvement in pain from baseline for each treatment. However, due to errors and inconsistencies, some of the text is difficult to interpret and may not be entirely accurate.*
Fig 6 (Fig 6)
Fig 7 (Fig 7)
Fig 9 (Fig 9)
The text shows a chart that compares the percent improvement in pain from baseline for patients taking different doses of Pregabalin and Placebo. It appears that patients taking daily doses of Pregabalin (300mg and 450mg) have a higher percent improvement in pain compared to those taking Placebo. The chart also shows the range of percent improvement from 20 to 80.*
Preg #90 (Pregabalin 300mg Cap Qty 90 Ndc 80425 0177)
This is a packing slip for a medication called Pregabalin, which comes in a capsule form with a strength of 100mg. The quantity packed is 90 capsules. The source or destination of the package is not mentioned, and the text "SOPRE3001221" may be a reference number or a date.*
Structure (Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
